ERBB2 and familial pancreatic carcinoma: To test this we incorporated the CAGs-LSL-RIK into two well-established models, specifically, a Cre-dependent, LSL-KrasG12D-driven pancreatic cancer model [13] and Cre-independent, MMTV-ErbB2 driven mammary cancer model [14].